TGF-β Signaling in Cranial Neural Crest Affects Late-Stage Mandibular Bone Resorption and Length

Area of Science:

• Craniofacial development and bone biology.

Background:

• Malocclusions, common craniofacial malformations, can lead to significant health and quality of life issues.
• Current treatments for severe skeletal malocclusion often involve invasive surgery.
• Understanding the cellular mechanisms of jaw bone length determination is crucial for developing improved therapies.

Purpose of the Study:

• To investigate the role of Transforming Growth Factor beta (TGF-β) signaling in neural crest mesenchyme (NCM) in regulating osteoclast activity and mandibular development.
• To determine if TGF-β signaling in NCM influences later stages of bone remodeling and embryonic jaw bone length.

Main Methods:

• Analysis of mouse embryos with targeted deletion of the TGF-β type I receptor (Tgfbr1) specifically in NCM.
• Micro-computed tomography (micro-CT) and Masson's trichrome staining to assess bone structure and quality.
• Gene expression analysis of key bone remodeling markers (Col1α1, Mmp13, Rank, Mmp9).
• Tartrate-resistant acid phosphatase (TRAP) staining to evaluate osteoclast localization and activity.
• Pharmacological inhibition of Tgfbr1 signaling during critical developmental windows.

Main Results:

• Mice with NCM-specific Tgfbr1 deficiency exhibited significantly shorter mandibles.
• No significant differences in overall bone quality (e.g., bone area, trabecular parameters, Col1α1, Mmp13 expression) were observed.
• A three-fold decrease in osteoclast number and perimeter was noted in Tgfbr1-deficient mandibles.
• Gene expression of osteoclast markers (Rank, Mmp9) was also reduced threefold.
• Pharmacological inhibition of Tgfbr1 signaling shortened embryonic jaw length.

Conclusions:

• TGF-β signaling within NCM is essential for regulating the number and activity of mesoderm-derived osteoclasts.
• This signaling pathway significantly impacts late embryonic jaw bone length.
• The precise mechanism of osteoblast-to-osteoclast communication mediated by TGF-β in NCM remains to be fully elucidated, suggesting a novel pathway.